March 23, 2026 · Form 4 insider transaction
UECKER DARRIN bought 100,000 shares of Pulse Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 11 days after the transaction.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.; The RSUs will fully vest on March 23, 2029, the three-year anniversary of the grant, subject to the Reporting Person's continued service through to that date.